Safety preliminary findings with the intravascular contrast agent NC100150 injection for MR coronary angiography

Journal of Magnetic Resonance Imaging

Volumn 9, Issue 2, 1999, Pages 220-227

  Taylor, Andrew M ^a,d   Panting, Jonathan R ^a   Keegan, Jennifer ^a   Gatehouse, Peter D ^a   Amin, Dipti ^b   Jhooti, Permi ^a   Yang, Guang Z ^c   McGill, Steven ^c   Burman, Elisabeth D ^a   Francis, Jane M ^a   Firmin, David N ^a   Pennell, Dudley J ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b Guy's Drug Research Unit Ltd   (United Kingdom)

^c NYCOMED IMAGING AS   (Norway)

^d UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Contrast agents; Coronary arteries; MRI; USPIO

Indexed keywords

ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; UNCLASSIFIED DRUG;

ADULT; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; DOSE RESPONSE; DRUG SAFETY; HUMAN; HUMAN EXPERIMENT; IMAGE ANALYSIS; IMAGE RECONSTRUCTION; INTRAVENOUS DRUG ADMINISTRATION; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; NORMAL HUMAN; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SIGNAL NOISE RATIO;

ADULT; CONTRAST MEDIA; CORONARY VESSELS; HUMANS; INJECTIONS, INTRAVENOUS; IRON; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; OXIDES; SAFETY;

EID: 0032968339     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199902)9:2<220::AID-JMRI11>3.0.CO;2-A     Document Type: Article

References (21)

1. Manning WJ, Li W, Edelman RR. A preliminary report comparing magnetic resonance coronary angiography with conventional angiography. N Engl J Med 1993;328:828-832.
2. Pennell DJ, Keegan J, Firmin DN, Gatehouse PD, Underwood SR, Longmore DB. Magnetic resonance imaging of coronary arteries: technique and preliminary results. Br Heart J 1993;70:315-326.
3. Prince MR, Grist TM, Debatin JF. 3D contrast MR angiography. Berlin: Springer Verlag; 1997.
4. Pennell DJ, Underwood SR, Longmore DB. Improved cine MR imaging of left ventricular wall motion with gadopentetate dimeglumine. J Magn Reson Imaging 1993;3:13-19.
5. Wilke N, Kroll K, Merkle H, et al. Regional myocardial blood volume and flow: first pass imaging with polylysine-Gd-DTPA. J Magn Reson Imaging 1995;5:227-237.
6. Mitchell DG. MR imaging contrast agents - what's in a name? J Magn Reson Imaging 1997;7:1-4.
7. McLachlan SJ, Morris MR, Lucas MA, et al. Phase I clinical evaluation of a new iron oxide MR contrast agent. J Magn Reson Imaging 1994;4:301-307.
8. Weissleder R, Stark DD, Engelstad BL, et al. Superparamagnetic iron oxide: pharmacokinetics and toxicity. AJR 1989;152:167-173.
9. Liu YL, Riederer SJ, Rossman PJ, Grimm RC, Debbins JP, Ehman RL. A monitoring, feedback, and triggering system for reproducible breath-hold MR imaging. Magn Reson Med 1993;30:507-511.
10. Wolfe SD, Balaban RS. Assessing contrast on MR images. Radiology 1996;202:25-29.
11. st ed. Released April 24, 1997.
12. Petersein J, Saini S, Weissleder R. Liver II: iron oxide-based reticuloendothelial contrast agents for MR imaging. Clinical review. Magn Reson Imaging Clin North Am 1996;4:53-60.
13. Anzai Y, Prince MR, Chenevert TL, et al. MR angiography with an ultrasmall superparamagnetic iron oxide blood pool agent. J Magn Reson Imaging 1997;7:209-214.
14. Taylor AM, Panting JR, Keegan J, et al. The use of the intravascular contrast agent NC100150 Injection in spin echo and gradient echo imaging of the heart. J Cardiovasc Magn Reson 1999;1:23-32.
15. Stillman AE, Wilke N, Li D, Haacke M, McLachlan S. Ultrasmall superparamagnetic iron oxide to enhance MRA of the renal and coronary arteries: studies in human patients. J Comput Assist Tomogr 1996;20:51-55.
16. th annual meeting of the International Society for Magnetic Resonance in Medicine. Vancouver: International Society for Magnetic Resonance in Medicine; 1997. p 442.
17. Goldfarb JW, Edelman RR. Coronary arteries: breath-hold, gadolinium-enhanced, three-dimensional MR angiography. Radiology 1998; 206:830-834.
18. Keegan J, Firmin D, Gatehouse P, Longmore D. The application of breath-hold phase velocity mapping techniques to the measurement of coronary artery blood flow velocity: phantom data and initial in vivo results. Magn Reson Med 1994;31:526-36.
19. Post JC, van Rossum AC, Hofman MBM, Valk J, Visser CA. Three-dimensional respiratory-gated MR angiography of coronary arteries: comparison with conventional coronary angiography. AJR 1996;166:1399-1404.
20. Li D, Kaushikkar S, Haacke EM, et al. Coronary arteries: three-dimensional MR imaging with retrospective respiratory gating. Radiology 1996;201:857-863.
21. Müller MF, Fleisch M, Kroeker R, Chatterjee T, Meier B, Vock P. Proximal coronary artery stenosis: three-dimensional MRI with fat saturation and navigator echo. J Magn Reson Imaging 1997;7:644-651.